Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journal
Can-Fite: Scientific Article Published by KOL Presents Namodenoson as a Promising Drug Candidate to Treat Advanced Liver Cancer and MASH
Can-Fite: Submits FDA with an IND Application to Conduct Phase IIb Clinical Trial of Namodenoson in MASH Patients
Can-Fite Reports 2023 Financial Results and Clinical Update
Can-Fite Broadens its Strong Intellectual Property (IP) for NASH
Can-Fite Expands the Out-Licensing Deal with Ewopharma
Can-Fite:Journal Published Positive Data from the COMFORT-1 PIII Psoriasis Study
The Anti-Obesity Effect of Can-Fite’s Namodenoson: Molecular Mechanism of Action in Pre-clinical and Human Studies
Can-Fite Received FDA Positive Response to Psoriasis Pediatric Plan
Can-Fite’s Namodenoson for the Treatment of Pancreatic Cancer Patients